Question: Remdesivir Was Developed To Treat Ebola Infections, But Has Been Approved To Treat Severe Cases Of COVID-19. What Is The Origin Of Remdesivir’s Activity Against Both Ebola And SARS-CoV-2? Additionally, What Is An Advantage Of Testing Compounds That Have Completed Phase 1 Trials? What Is A Disadvantage?
Remdesivir was developed to treat Ebola infections, but has beenapproved to treat severe cases of COVID-19. What is the origin ofremdesivir’s activity against both Ebola and SARS-CoV-2?Additionally, what is an advantage of testing compounds that havecompleted phase 1 trials? What is a disadvantage?
Is this your assignment or some part of it?
We can do it for you! Click to Order!
